Showing results (941-950 of 957) with videos related to

Sort By:
Pageof 96
Gigascience|March 6, 2015
Phylogenomic analyses data of the avian phylogenomics projectErich D Jarvis, Siavash Mirarab, Andre J Aberer, et al.
Plos Genetics|February 9, 2010
Genetic and functional dissection of HTRA1 and LOC387715 in age-related macular degenerationZhenglin Yang, Zongzhong Tong, Yuhong Chen, et al.
Plos One|February 6, 2013
Hemoglobinopathy: molecular epidemiological characteristics and health effects on Hakka people in the Meizhou region, southern ChinaMin Lin, Ying-Fang Wen, Jiao-Ren Wu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 15, 2026
EXPRESS: Stroke-induced immunosuppression is associated with brain injury and poor outcomes in patients receiving intravenous thrombolysis: a multicenter prospective cohort studyZhong-Yu Cao, Yang Qu, Ze-Yu Hao, et al.
Medcomm|August 14, 2023
Clinical evaluation of a multitarget fecal immunochemical test-sDNA test for colorectal cancer screening in a high-risk population: a prospective, multicenter clinical studyYe-Ting Hu, Xiao-Feng Chen, Chun-Bao Zhai, et al.
BMC Medicine|October 2, 2024
The association between serum S100β levels and prognosis in acute stroke patients after intravenous thrombolysis: a multicenter prospective cohort studyYang Qu, Hang Jin, Reziya Abuduxukuer, et al.
Gigascience|February 12, 2015
Two Antarctic penguin genomes reveal insights into their evolutionary history and molecular changes related to the Antarctic environmentCai Li, Yong Zhang, Jianwen Li, et al.
ACS Medicinal Chemistry Letters|July 23, 2014
Investigation of Cardiovascular Effects of Tetrahydro-β-carboline sstr3 antagonistsShuwen He, Zhong Lai, Zhixiong Ye, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 DiabetesShuwen He, Zhixiong Ye, Quang Truong, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 DiabetesShrenik K Shah, Shuwen He, Liangqin Guo, et al.
Pageof 96